Cepheid is developing a rapid test, known as Xpert Carba-R, for detecting multidrug-resistant pathogens. The test has several advantages over existing diagnostic methods. The company successfully ...

Sherlock Biosciences has teamed up with Cepheid to help develop its CRISPR-based molecular diagnostic tech for new tests on the latter’s automated laboratory systems. The collaboration will focus on ...

PARIS & CAMBRIDGE, England--(BUSINESS WIRE)--Regulatory News: Novacyt (ALTERNEXT: ALNOV), an international specialist in clinical diagnostics, today announces it has entered into a strategic alliance ...

Q3 2025 Management View CEO Rainer Blair emphasized strong third quarter results, driven by "DBS-driven execution paired with ...

(RTTNews) - Cepheid, a unit of Danaher Corp. (DHR), said Thursday that it has received a medical device license from Health Canada for Xpert Xpress SARS-CoV-2/Flu/RSV, a rapid molecular diagnostic ...

Shares in biotechnology, life sciences, and diagnostics company Danaher (NYSE: DHR) rose by as much as 12.9% in early morning ...

Cepheid said it will partner with MedImmune and a European public/private partnership that promotes anti-infective drug development to develop rapid diagnostic tests in respiratory secretions of ...

The all-cash deal will expand Danaher's already hefty life sciences division. D.C.-based Danaher Corp. (NYSE: DHR) is buying California molecular diagnostics company Cepheid Inc. (NASDAQ: CPHD) for ...

(Reuters) - Molecular diagnostics company Cepheid said it received a grant of up to $3.3 million, co-financed by the Paul G. Allen Family Foundation and the Bill & Melinda Gates Foundation, to develop ...

Danaher Corp. said Monday it has agreed to acquire diagnostics company Cepheid for $53 a share in cash or about $4 billion. Danaher said it expects to finance the deal with cash and debt. Cepheid had ...

Science, health care and technology conglomerate Danaher Corp.DHR-1.46%decrease; red down pointing triangle said Tuesday that it would buy molecular-diagnostics company Cepheid Inc. for $53.00 a share ...